- Dementia Carers Together is an appeal run by Mail Force in association with Alzheimer's Society, delivering vital support to the UK's unpaid dementia carers
- To donate, visit the Dementia Carers Together fundraising page
asserted
Together → run → page
A new once-a-day pill that acts like 'Viagra for the brain' has been shown to slow clinical decline in Alzheimer's patients by a third.
asserted
that → act → third
The blockbuster therapy delayed progression of the disease by the equivalent of 3.5 months after just one year in a major phase III trial.
asserted
therapy → delay → trial
Participants given the drug, known as AR1001 and made by South Korean pharmaceutical firm AriBio, performed 31 per cent better in an assessment of memory, thinking and everyday functioning than those given a placebo.
asserted
Participants → give → placebo
Results presented at the Clinical Trials on Alzheimer's Disease conference in Boston, United States, this evening suggest it is the first oral treatment to successfully target an underlying cause of the disease, rather than simply tackle symptoms.
asserted
it → present → symptoms
Other disease-modifying therapies, such as lecanemab and donanemab, have to be given by infusion in a clinic or by injection and have not been approved for use on the NHS because of the high cost of administering them.
asserted
therapies → modify → them
Having an alternative in tablet form could significantly lower the cost and provide an attractive option to people who dislike needles.
uncertain
who → have → needles
The new drug's active ingredient, mirodenafil, belongs to the same class of drugs as sildenafil, which is found in Viagra and used to treat erectile dysfunction.
asserted
which → belong → dysfunction
They both work to block an enzyme called PDE5, which in turn relaxes blood vessels and increases blood flow.
asserted
which → work → flow
The new drug's active ingredient, mirodenafil, belongs to the same class of drugs as sildenafil, which is found in Viagra and used to treat erectile dysfunction.
asserted
which → belong → dysfunction
AR1001 is thought to have a number of beneficial effects in the brain, including lowering inflammation, increasing blood flow and protecting nerve cells.
asserted
AR1001 → think → cells
The global trial involved 1,535 people with Alzheimer's from 230 sites in 13 countries, including the United Kingdom.
asserted
trial → involve → Kingdom
Researchers found the 31 per cent benefit among patients who were not taking any other dementia medications, known as the 'monotherapy' group.
asserted
who → find → group
A lesser benefit of 7 per cent was found among those who took AR1001 alongside other dementia drugs but this was not considered statistically significant.
asserted
this → find → drugs
AR1001 operates differently to existing disease-modifying treatments lecanemab and donanemab, which help remove amyloid plaque from the brain.
asserted
which → operate → brain
Most side effects reported in the trial were mild or moderate, with the most common being diarrhoea, falls and dizziness.
asserted
common → report → trial
Some 69 per cent of people receiving AR1001 reported side effects, compared to 66.4 per cent receiving the placebo.
asserted
cent → receive → placebo
AriBio also looked at markers of Alzheimer's disease in cerebrospinal fluid and found lower levels of ptau217, which is tested to identify the presence of both amyloid and tau - hallmarks of Alzheimer's in the brain.
asserted
which → look → brain
The findings come as the Daily Mail's Dementia Carers Together Appeal is raising money for new six-week courses for friends and relatives of people living with the disease.
asserted
Appeal → come → disease
Delivered in partnership with Alzheimer's Society and the Mail Force charity, the sessions will give carers vital support and information about their rights and the services available to them.
asserted
sessions → deliver → them
They will allow attendees to meet others in a similar situation and help to address the loneliness, exhaustion and overwhelming responsibilities many face following a loved one's diagnosis.
asserted
many → allow → diagnosis
Dr Richard Oakley, Associate Director for Research and Innovation at Alzheimer's Society, said: 'These topline results are an encouraging sign that we could have a new treatment for early Alzheimer's disease that tackles its causes, not just its symptoms.
'
uncertain
that → say → causes
Over the year of the trial, the drug was able to slow down people's decline in memory and thinking by nearly a third.
asserted
drug → slow → third
However, results were not apparent in people taking other drugs for Alzheimer's symptoms, so this needs further investigation.
asserted
this → take → investigation
AR1001 works differently from other disease-modifying treatments we've seen so far and, as a once-a-day tablet, could offer a simpler way for people to receive treatment.
uncertain
people → work → treatment
Reported side effects were mostly mild to moderate in severity.
asserted
effects → report → severity
This drug is from the same family of medicines as Viagra, but it is being developed specifically for Alzheimer's disease.
asserted
it → develop → disease
People should not take Viagra to try to treat Alzheimer's.
asserted
People → take → Alzheimer
It's important to note AR1001 is not yet available to the public and will need to be assessed and approved by UK regulatory bodies before it could be offered in the UK.
uncertain
it → note → UK
'Research is making huge progress and will beat dementia – and as more potential treatments emerge, it's more important than ever that people get an early and accurate dementia diagnosis so they can benefit from them.
asserted
they → make → them
We look forward to seeing the full results from this trial and how this drug progresses.'
asserted
drug → look → trial
Dr David Greeley, a leading clinical researcher in Alzheimer's drug development at Northwest Neurological, in the United States, said: 'As a practicing neurologist and clinical investigator for over thirty years - as well as an investigator for AriBio since Phase 2 - I see
asserted
I → lead → Phase
how urgently patients and families need treatments for Alzheimer's disease.
asserted
patients → need → disease
The findings in the pre-specified Monotherapy population of the AriBio study recently released are very encouraging and support the premise of a once-daily oral approach to this devastating disease.
asserted
findings → release → disease
If approved, this oral drug would broaden patients' options.
asserted
drug → approve → options
Further evaluation is needed, but our goal is meaningful treatment that not only helps patients but that can be realistically afforded, received and sustained.'
asserted
that → need → patients